| __timestamp | Arrowhead Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 15635076 |
| Thursday, January 1, 2015 | 57410147 | 23943601 |
| Friday, January 1, 2016 | 41454452 | 23689111 |
| Sunday, January 1, 2017 | 31690298 | 41006114 |
| Monday, January 1, 2018 | 52968505 | 51379106 |
| Tuesday, January 1, 2019 | 81048686 | 32705593 |
| Wednesday, January 1, 2020 | 128874979 | 53274000 |
| Friday, January 1, 2021 | 206342000 | 85352000 |
| Saturday, January 1, 2022 | 297307000 | 51999000 |
| Sunday, January 1, 2023 | 353188000 | 59471000 |
| Monday, January 1, 2024 | 505870000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Summit Therapeutics Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Arrowhead Pharmaceuticals has consistently increased its R&D spending, peaking at an impressive 353% growth by 2023 compared to 2014. This strategic focus underscores Arrowhead's dedication to advancing its pipeline and maintaining a competitive edge.
Conversely, Summit Therapeutics has shown a more fluctuating pattern, with its highest R&D expenditure in 2021, marking a 446% increase from 2014. However, the data for 2024 is missing, leaving a gap in understanding their current strategy. This divergence in R&D spending highlights the varied approaches these companies take in navigating the dynamic biotech landscape.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.